Meet The Speaker
About
Imre Molnár
Imre Molnár has more than 35 years of experience in the field of HPLC. He specializes in pharmaceutical research and analysis and works with industrial and academic groups on research topics in pharmaceutical and biopolymer analysis.
Born in Budapest, Hungary, Dr. Imre Molnár studied at the University of Saarbrücken, which at the time was a "Special Research Center for Analytical Chemistry" in Germany. He received his PhD in 1975 with a thesis study on a separation technique for instable non-metallic compounds and spent the following two years as a postdoctoral fellow at the Department of Bioengineering at Yale University in New Haven, Connecticut, USA, studying with Csaba Horváth, a pioneer in the technique of "High Pressure Liquid Chromatography" (HPLC). From this collaboration, eleven papers were published, the three most import of which describe the fundamentals of "Reversed-Phase Chromatography" (RPC) — in particular, the much-cited Theory of Solvophobic Interactions.
Following his post-doctorate, Dr. Imre Molnár returned to Europe to work on the development of HPLC instrumentation, founding the Institute for Applied Chromatography in Berlin in 1981. During that time, he also started teaching Reversed-Phase Chromatography both at Free University of Berlin and at pharmaceutical companies throughout Europe.
In 1984, Dr. Imre Molnár began working with Lloyd R. Snyder, John W. Dolan, and Tom Jupille of LC Resources Inc. (Walnut Creek, CA, USA) on the development of DryLab, which is now widely used in both the pharmaceutical industry and the life science community. There are more than 260 scientific papers published on applications of DryLab, which is a software tool for modeling complex separation processes in (U)HPLC, enabling the user to minimize the number of experiments required to develop an optimized method.
In 2006 the Molnár Institute obtained full rights to DryLab and has continued its development, adding peak matching capabilities, multiple parameter optimization (3D resolution maps), robustness testing features, and GMP-compliant method reporting.